Photo of Krystal Cascetta
Accepting New Patients

Krystal P Cascetta, MD Email Krystal Cascetta

Hematology-Oncology
Doctor magenta, checkmark badge icon
Mount Sinai Doctors ?
    • Position
    • ASSISTANT PROFESSOR | Medicine, Hematology and Medical Oncology
    • Specialty
    • Hematology-Oncology
    • Languages
    • Spanish
    • Italian
    • English
    • Hospital Affiliations
    • The Mount Sinai Hospital
    • Mount Sinai Morningside and Mount Sinai West
    • Mount Sinai Queens
    • Phone
    • Mount Sinai Queens Infusion Center 718-808-7375
    • Mount Sinai, Jackson Heights 718-879-1600
Request an Appointment

Krystal P. Cascetta, MD, is an Assistant Professor of Medicine within the Division of Hematology and Medical Oncology at the Icahn School of Medicine at Mount Sinai. She is also Director of Operations at the Mount Sinai Queens Infusion Center, a state-of-the-art treatment center for cancer and blood disorders and an extension of the Tisch Cancer Institute at The Mount Sinai Hospital.  Dr. Cascetta is board certified in Internal Medicine, Hematology and Medical Oncology. She received her medical degree from Albany Medical College where she was inducted into the Gold Humanism Honor Society for demonstrating excellence in humanistic clinical care, leadership, compassion and dedication to service. Dr. Cascetta went on to complete residency training in internal medicine at the Hofstra North Shore LIJ School of Medicine at North Shore University Hospital, Manhasset, New York and at LIJ Medical Center in New Hyde Park, New York. As a resident, she received the Intern of the Year award, Humanism in Medicine award and the Daniel Ross Gold, DO Resident Teacher of the Year award. She then completed a fellowship program in Hematology and Medical Oncology at the Mount Sinai Hospital where she served as Chief Fellow.


Dr. Cascetta is conducting a number of research projects.  She is pursuing the clinical investigation of breast malignancy, with a particular focus on cyclin D1 expression in breast carcinoma as well as the clinical and pathologic factors that predict for Oncotype Dx discordance. She is also examining the use of an aromatase inhibitor, palbociclib, trastuzumab and pertuzumab in women with metastatic hormone receptor-positive, HER2neu-positive breast cancer.

Her clinical focus includes the treatment of breast cancer, gynecologic cancer: cervical, ovarian and uterine, sarcoma and gastrointestinal cancers: esophageal, gastric, liver, pancreas, small intestine, colorectal, and anal. She works closely with her colleagues in surgical oncology, radiation oncology, pathology and internal medicine in order to provide comprehensive and integrated care to her patients.

She is a member of the American Society of Clinical Oncology and the American Society of Hematology.
 

Certification

American Board of Internal Medicine

Clinical Focus

Education

MD, Albany Medical College

Residency, Internal Medicine
Long Island Jewish Medical Center

Fellowship, Hematology/Oncology
Mount Sinai School of Medicine

Languages

Spanish, Italian, English